22nd Century Group Inc (XXII)

[nonameface13]

Can we put this in bold, please? :)

TPSAC Meeting in February 2020 to Discuss 22nd Century Group Inc. MRTP Applications

FDA has issued a Federal Register notice announcing a meeting of the Tobacco Products Scientific Advisory Committee (TPSAC) scheduled for Feb. 14, 2020, at FDA's White Oak Campus. The committee will discuss scientific issues related to the modified risk tobacco product (MRTP) applications submitted by 22nd Century Group Inc. for VLN TM King and VLN TM Menthol King combusted, filtered cigarettes, which are currently under scientific review by FDA. These products recently received marketing authorization under the names Moonlight® and Moonlight® Menthol.

Please refer to the Federal Register notice for instructions on how to submit public comments related to TPSAC. Requests to present an oral comment at the February 2020 meeting must be received by Jan. 30, 2020. Written comments related to the TPSAC meeting must be received by Feb. 7, 2020.

These deadlines apply only to the TPSAC meeting and do not apply to the public docket for 22nd Century Group Inc.’s MRTP applications. There is currently no deadline for public comments on these applications.